Department of Psychiatry, University of Naples SUN, Largo Madonna delle Grazie, I-80138 Naples, Italy.
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):323-30. doi: 10.1016/j.pnpbp.2009.12.007. Epub 2009 Dec 16.
Available evidence about the relationship between poor insight and other clinical characteristics in patients with obsessive-compulsive disorder (OCD) is inconclusive and conflicting. There is also a paucity of data on the long-term course and treatment outcome of OCD patients with poor insight. The present study reports the findings of a relatively large sample (n=106) of outpatients fulfilling DSM-IV criteria for OCD, treated with serotonin reuptake inhibitors (SRIs) and prospectively followed up for 3 years. Baseline information was collected on demographic and clinical characteristics, using standardized instruments. Insight was assessed by means of the Brown Assessment of Beliefs Scale (BABS). Eighty-three patients were followed prospectively and evaluated systematically by validated measures of psychopathology. Compared to their good insight counterparts, the OCD patients with poor insight (22%) showed a greater severity of obsessive-compulsive and depressive symptomatology; an earlier age at onset; a higher rate of schizophrenia spectrum disorder in their first-degree relatives; a higher comorbidity with schizotypal personality disorder. During the follow-up period, poor insight OCD patients were less likely to achieve at least a partial remission of obsessive-compulsive symptoms; required a significantly greater number of therapeutic trials; received more frequently augmentation with antipsychotics. The results suggest that the specifier "poor insight" helps to identify a subgroup of patients at the more severe end of OCD spectrum, characterized by a more complex clinical presentation, a diminished response to standard pharmacological interventions, and a poorer prognosis. Further research is needed to identify alternative strategies for the management of these patients.
目前关于强迫症(OCD)患者洞察力缺失与其他临床特征之间关系的证据尚无定论且相互矛盾。关于洞察力缺失的 OCD 患者的长期病程和治疗结果的数据也很少。本研究报告了一项相对较大样本(n=106)的门诊患者的研究结果,这些患者符合 DSM-IV OCD 标准,接受了选择性 5-羟色胺再摄取抑制剂(SSRIs)治疗,并前瞻性随访了 3 年。使用标准化工具收集了人口统计学和临床特征的基线信息。通过布朗信念量表(BABS)评估洞察力。83 名患者进行了前瞻性随访,并使用经过验证的精神病理学测量工具进行了系统评估。与洞察力良好的患者相比,洞察力缺失的 OCD 患者(22%)表现出更严重的强迫和抑郁症状;发病年龄更早;一级亲属中精神分裂症谱系障碍的发生率更高;与精神分裂型人格障碍的共病率更高。在随访期间,洞察力缺失的 OCD 患者不太可能至少部分缓解强迫症状;需要进行更多的治疗试验;更频繁地需要增效抗精神病药物。研究结果表明,“洞察力缺失”这一特征有助于识别 OCD 谱系中更严重的亚组患者,其特征为更复杂的临床表现、对标准药物干预反应减弱以及预后较差。需要进一步研究来确定这些患者的替代管理策略。